ENDONOVO THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $4.2M | $73.6K | $3.3K |
| FY2014 | $4.7M | $45.6K | $988 |
| FY2015 | $9.7M | $409.4K | $41.5K |
| FY2016 | $8.9M | $318.7K | $55.5K |
| FY2017 | $14.2M | $4.6M | $90.2K |
| FY2018 | $15.6M | $4.2M | $379.2K |
| FY2019 | $23.8M | $3.3M | $18.9K |
| FY2020 | $17.0M | $2.6M | $13.4K |
| FY2021 | $17.8M | $2.0M | $85.9K |
| FY2022 | $33.5M | $1.3M | — |